NCT06072521View on ClinicalTrials.gov

Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

October 31, 2024

Conditions
Hepatic Encephalopathy
Interventions
DRUG

Lactoferrin Bovine

Lactoferrin bovine with concentration 100 mg will be given to the patients in test groups in the form of sachets.

Trial Locations (1)

Unknown

National hepatology and tropical medicine research institute, Cairo

All Listed Sponsors
lead

Al-Azhar University

OTHER